Targeting the adenosinergic system in restless legs syndrome: A pilot, "proof-of-concept" placebo-controlled TMS-based protocol. Lanza G, Salemi M, Mogavero MP, Catania V, et al. PLoS One 2024;19:e0302829.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Lanza G, Salemi M, Mogavero MP, Catania V, et al. Targeting the adenosinergic system in restless legs syndrome: A pilot, "proof-of-concept" placebo-controlled TMS-based protocol. PLoS One 2024;19:e0302829.
PMID: 38728342